Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients

Table 2

Seven anoikis-related signatures greatly correlated with survival outcome.

Gene	Coefficient	Hazard ratio (95% CI)	value
CDKN2A	0.1068	1.29 (1.16–1.45)	<0.001
E2F1	0.0941	1.48 (1.21–1.82)	<0.001
ENDOG	-0.2316	0.71 (0.54–0.92)	0.011
EZH2	0.1626	1.52 (1.12–2.07)	0.007
HMGA1	0.8872	1.26 (1.04–1.53)	0.012
PLK1	0.1673	1.36 (1.07–1.73)	0.011
SLC2A1	0.0228	1.22 (1.02–1.46)	0.028